C4 Therapeutics, Inc. Shares Outstanding (Cover Page)
C4 Therapeutics, Inc. (CCCC) had Shares Outstanding (Cover Page) of 123.03 million shares as of 2026-07-31, per its 10-Q filed 2026-08-11.
Financial Statements › Notes › Cover Page
dei:EntityCommonStockSharesOutstanding · last filed 2026-08-11
- 2026-07-31: Entity Common Stock, Shares Outstanding 123.03M shares.
- 2026-05-01: Entity Common Stock, Shares Outstanding 110.57M shares.
- 2026-02-23: Entity Common Stock, Shares Outstanding 97.58M shares.
- 2025-10-29: Entity Common Stock, Shares Outstanding 96.91M shares.
| Period end | Entity Common Stock, Shares Outstanding |
|---|---|
| 2026-07-31 | 123.03M shares 10-Q · filed 2026-08-11 |
| 2026-05-01 | 110.57M shares 10-Q · filed 2026-05-12 |
| 2026-02-23 | 97.58M shares 10-K · filed 2026-02-26 |
| 2025-10-29 | 96.91M shares 10-Q · filed 2025-11-06 |
| 2025-07-29 | 71.17M shares 10-Q · filed 2025-08-07 |
| 2025-05-01 | 71.01M shares 10-Q · filed 2025-05-07 |
| 2025-02-20 | 70.99M shares 10-K · filed 2025-02-27 |
| 2024-10-24 | 70.59M shares 10-Q · filed 2024-10-31 |
| 2024-07-30 | 69.34M shares 10-Q · filed 2024-08-01 |
| 2024-04-30 | 68.81M shares 10-Q · filed 2024-05-08 |
| 2024-02-14 | 68.60M shares 10-K · filed 2024-02-22 |
| 2023-10-25 | 49.28M shares 10-Q · filed 2023-11-01 |
| 2023-07-31 | 49.19M shares 10-Q · filed 2023-08-08 |
| 2023-04-25 | 49.06M shares 10-Q · filed 2023-05-04 |
| 2023-02-15 | 49.05M shares 10-K · filed 2023-02-23 |
| 2022-10-26 | 48.96M shares 10-Q · filed 2022-11-03 |
| 2022-07-27 | 48.91M shares 10-Q · filed 2022-08-04 |
| 2022-04-25 | 48.80M shares 10-Q · filed 2022-05-05 |
| 2022-02-15 | 48.74M shares 10-K · filed 2022-02-24 |
| 2021-11-01 | 48.63M shares 10-Q · filed 2021-11-10 |
| 2021-08-02 | 48.45M shares 10-Q · filed 2021-08-11 |
| 2021-05-03 | 43.20M shares 10-Q · filed 2021-05-13 |
| 2021-03-01 | 43.12M shares 10-K · filed 2021-03-11 |
| 2020-11-10 | 43.03M shares 10-Q · filed 2020-11-12 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| FENNEC PHARMACEUTICALS INC. (FENC) | United States | $0.371B | -115.85 |
| Artiva Biotherapeutics, Inc. (ARTV) | United States | $0.367B | |
| Cabaletta Bio, Inc. (CABA) | United States | $0.365B | -2.81 |
| AGENUS INC (AGEN) | United States | $0.383B | 1.41 |
| Surrozen, Inc./DE (SRZN) | United States | $0.395B | |
| Zura Bio Ltd (ZURA) | $0.398B | -6.56 | |
| Ocugen, Inc. (OCGN) | United States | $0.343B | -6.34 |
| Scribe Therapeutics, Inc. (SCTX) | United States | $0.410B | |
| Editas Medicine, Inc. (EDIT) | United States | $0.424B | -4.29 |
| Kyverna Therapeutics, Inc. (KYTX) | United States | $0.434B | -3.60 |